7Baggers
 Published on: 2025-11-15 21:38:05  newser.com Sun, 16 Nov 2025 03:38:05 GMT
 bioxcel therapeutics: a race against time  AD HOC NEWS Fri, 14 Nov 2025 06:13:04 GMT
 BioXcel Therapeutics’ Q3 2025 Earnings and Clinical Updates  TipRanks Thu, 13 Nov 2025 04:33:22 GMT
 [DEF 14A] BioXcel Therapeutics, Inc. Definitive Proxy Statement  Stock Titan Wed, 12 Nov 2025 22:00:18 GMT
 btai q3 revenue misses expectations, focus on future growth  GuruFocus Wed, 12 Nov 2025 12:43:36 GMT
 BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)  TipRanks Wed, 12 Nov 2025 12:17:45 GMT
 BioXcel Therapeutics Q3 revenue misses analyst expectations  TradingView Wed, 12 Nov 2025 12:09:49 GMT
 bioxcel presents phase 3 study on bxcl501  MSN Mon, 10 Nov 2025 08:00:00 GMT
 New Haven’s BioXcel weathers turmoil to regain footing and market confidence  Hartford Business Journal Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-11-03 03:37:33  newser.com Mon, 03 Nov 2025 09:37:33 GMT
 published on: 2025-11-03 01:00:44  newser.com Mon, 03 Nov 2025 07:00:44 GMT
 published on: 2025-11-03 00:33:12  newser.com Mon, 03 Nov 2025 06:33:12 GMT
 published on: 2025-11-02 05:48:35  newser.com Sun, 02 Nov 2025 10:48:35 GMT
 published on: 2025-11-01 08:49:34  newser.com Sat, 01 Nov 2025 13:49:34 GMT
 btai sets dec 12 virtual annual meeting; board backs all items  Stock Titan Fri, 31 Oct 2025 21:36:41 GMT
 [PRE 14A] BioXcel Therapeutics, Inc. Preliminary Proxy Statement  Stock Titan Fri, 31 Oct 2025 21:15:19 GMT
 bioxcel therapeutics updates snda timeline for igalmi®  MSN Fri, 31 Oct 2025 01:08:02 GMT
 bioxcel therapeutics updates on igalmi® snda submission  TradingView Thu, 30 Oct 2025 11:25:00 GMT
 BioXcel Therapeutics Updates sNDA Timeline for IGALMI®  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 published on: 2025-10-30 01:42:19  newser.com Thu, 30 Oct 2025 06:42:19 GMT

BioXcel Therapeutics, Inc
(NASDAQ:BTAI) 

BTAI stock logo

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic re...

Founded: 2017
Full Time Employees: 40
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends